Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Induction Gemcitabine and Cisplatin in NPC
NCT01872962Phase 3Unknown
- Sponsor
- Sun Yat-sen University
- Start
- Nov 2013
- Primary completion
- Nov 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of gemcitabine in nasopharyngeal carcinoma (NPC), sponsored by Sun Yat-sen University. Status: unknown.
02
Drugs
gemcitabine
03
Conditions
nasopharyngeal carcinoma (NPC)
Beyond the preview
Go deeper on NCT01872962.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01872962.